vTv Therapeutics Inc. Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount
vTv Therapeutics Inc. (VTVT) reported Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount · last filed 2026-03-10
- vTv Therapeutics Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2024-12-31 was $0.00.
- vTv Therapeutics Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2023-12-31 was $0.00.
- vTv Therapeutics Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2023-09-30 was $4.20M.
- vTv Therapeutics Inc. equity securities without readily determinable fair value, impairment loss, annual amount for the quarter ending 2022-12-31 was $0.00.
- vTv Therapeutics Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2025 was $0.00.
- vTv Therapeutics Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- vTv Therapeutics Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2023 was $4.25M.
- vTv Therapeutics Inc. equity securities without readily determinable fair value, impairment loss, annual amount for fiscal 2022 was $0.00.
| Period end | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 3 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 6 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 9 month | Equity Securities without Readily Determinable Fair Value, Impairment Loss, Annual Amount 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-10 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $0.00 10-K · filed 2026-03-10 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $4.20M derived: sum of 2 quarters · filed 2026-03-10 | $4.25M 10-K · filed 2026-03-10 | |
| 2023-09-30 | $4.20M 10-Q · filed 2023-11-09 | $4.25M 10-Q · filed 2024-11-12 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $0.00 10-K · filed 2025-03-20 | ||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-03-13 |